Received Mar 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUAD) | SEQIRUS, INC. | N/A | 388490 | IM / RA |
| RSV | RSV (ABRYSVO) | PFIZER\WYETH | N/A | LG9828 | IM / LA |
66 with notable PMH of HIV and HSV received flu vax (>65) in right delt and RSV vax in left delt at internal medicine clinic. pt had received flu vaccine prior (last admin documented in 2020), however this was pt's first time receiving 65+ vax. this was also first time receiving RSV vax. after vaccine administration, pt reported feeling dizzy and weak, and RRT was called and pt was transported to ED. Pt reported that her partner had some sort of viral illness prior to visit, but reported feeling well in ED other than body aches. Pt was admitted for observation and ultimately diagnosed with HRV. No notable events occurred during admission and pt was discharged the next day
Patient's cough appears to be most consistent with lingering cough from viral URI; administered influenza and RSV vaccines on same day, but no other vaccines documented since Oct 2022
HIV (on ART), HSV